Form D · Pharmaceuticals
Skyline Vet Pharma, Inc.
Groton, CT · CIK 0001680111
Offering snapshot reported Apr 12, 2017 · SEC filing
- Reported sold
- $5.01M Offering amount: $5.01M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2017 | Initial | $5,011,760 | No comparison | 23 | SEC filing |
| Jul 25, 2016 | Initial | $1,423,928 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-284572
Source: Form D, filed Apr 12, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph C. Cook, Jr. | Director |
| John W. Dombrosky | Director |
| Serge R Martinod, Dvm, Ph D | Director, Executive |
| George F Murphy, Jr. | Director, Executive |
| Alastair J Riddell | Director |
| David K. Rosen | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
37 Skyline Drive
Groton, CT, 06340
Groton, CT, 06340